Joshua Ostrenga, MA

Senior Biostatistician
Cystic Fibrosis Foundation

Poster(s):

• (25) Impact of repeated non-treatment on long-term lung function
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (33) Cystic Fibrosis in the United States by 2040: a population landscape analysis
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (54) Updated estimates of CF prevalence and participation in the Cystic Fibrosis Foundation Patient Registry in the United States
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (149) Survival outcomes following liver transplantation for individuals with cystic fibrosis living in North America
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (353) Risk Factors Associated with Meeting the Standard of Care and Use of Telehealth in 2020 among Persons with Cystic Fibrosis in the United States
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (361) Distribution and cost of common CF prescription drugs using claims data
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET